Sakar Healthcare is coming out with a 100% book building; initial public offering (IPO) of 29,61,000 equity shares of Rs 10 each in a price band Rs 42-50 per equity share. The issue will open on September 30, 2016 and will close on October 05, 2016. The shares will be listed on NSE Emerge platform.
The company will use the issue proceeds for setting up a new Lyophilization facility to manufacture Lyophilized Products (Injectable) in existing unit at Changodar, Ahmedabad, Gujrat, obtaining registration of European Union GMP, registering new products, meeting working capital requirement and meeting general corporate purposes.
The book running lead manager to the issue is Pantomath Capital Advisors, while the compliance officer for the issue is Pratixa Seju.
The company is an Indian pharmaceutical company engaged in the manufacturing and marketing of its own pharmaceutical formulations for domestic and international markets. Its Product domestic sales are generally exported by third party. It also undertakes contract manufacturing of formulations for pharmaceutical companies based in India.